Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition
Background: Hepatocellular carcinoma (HCC) represents a major health burden with limited curative treatment options. There is a substantial unmet need to develop innovative approaches to impact the progression of advanced HCC. Haprolid is a novel natural component isolated from myxobacteria. Haproli...
Main Authors: | Jun Xing, Vikas Bhuria, Khac Cuong Bui, Mai Ly Thi Nguyen, Zexi Hu, Chih-Jen Hsieh, Kathrin Wittstein, Marc Stadler, Ludwig Wilkens, Jun Li, Markus Kalesse, Przemyslaw Bozko, Ruben R. Plentz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/615 |
Similar Items
-
The anti‐metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2‐dependent manner
by: Lan Thi Hanh Phi, et al.
Published: (2018-11-01) -
Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
by: Chen W, et al.
Published: (2018-07-01) -
Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition
by: Grégory Fouquet, et al.
Published: (2022-02-01) -
Homeobox Genes and Hepatocellular Carcinoma
by: Kwei-Yan Liu, et al.
Published: (2019-05-01) -
Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
by: Qikuan He, et al.
Published: (2022-08-01)